| Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET P Tylski, S Stute, N Grotus, K Doyeux, S Hapdey, I Gardin, B Vanderlinden, ... Journal of nuclear medicine 51 (2), 268-276, 2010 | 175 | 2010 |
| Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia … P Vera, P Bohn, A Edet-Sanson, A Salles, S Hapdey, I Gardin, JF Ménard, ... Radiotherapy and Oncology 98 (1), 109-116, 2011 | 144 | 2011 |
| Management of respiratory motion in PET/computed tomography: the state of the art. A Pépin, J Daouk, P Bailly, S Hapdey, ME Meyer Nuclear medicine communications 35 (2), 113-22, 2014 | 135 | 2014 |
| Quantitative accuracy of dopaminergic neurotransmission imaging with 123I SPECT M Soret, PM Koulibaly, J Darcourt, S Hapdey, I Buvat Journal of Nuclear Medicine 44 (7), 1184-1193, 2003 | 129 | 2003 |
| Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models S Vauclin, K Doyeux, S Hapdey, A Edet-Sanson, P Vera, I Gardin Physics in Medicine & Biology 54 (22), 6901, 2009 | 99 | 2009 |
| Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study) P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of Nuclear Medicine 58 (7), 1045-1053, 2017 | 86 | 2017 |
| Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC) A Edet-Sanson, B Dubray, K Doyeux, A Back, S Hapdey, R Modzelewski, ... Radiotherapy and Oncology 102 (2), 251-257, 2012 | 67 | 2012 |
| Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma AS Cottereau, S Hapdey, L Chartier, R Modzelewski, O Casasnovas, E Itti, ... Journal of Nuclear Medicine 58 (2), 276-281, 2017 | 62 | 2017 |
| Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma C Lemarignier, F Di Fiore, C Marre, S Hapdey, R Modzelewski, P Gouel, ... European journal of nuclear medicine and molecular imaging 41, 2008-2016, 2014 | 58 | 2014 |
| Does recombinant human thyrotropin-stimulated positron emission tomography with [18F] fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid … P Vera, C Kuhn-Lansoy, A Edet-Sanson, S Hapdey, R Modzelewski, ... Thyroid 20 (1), 15-23, 2010 | 57 | 2010 |
| FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer S Thureau, B Dubray, R Modzelewski, P Bohn, S Hapdey, S Vincent, ... Radiation oncology 13, 1-7, 2018 | 42 | 2018 |
| Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome … P Vera, SD Mihailescu, J Lequesne, R Modzelewski, P Bohn, S Hapdey, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1448-1456, 2019 | 40 | 2019 |
| Biases affecting the measurements of tumor-to-background activity ratio in PET M Soret, C Riddell, S Hapdey, I Buvat IEEE Transactions on Nuclear Science 49 (5), 2112-2118, 2002 | 34 | 2002 |
| New fetal dose estimates from 18F-FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms P Zanotti-Fregonara, M Chastan, A Edet-Sanson, O Ekmekcioglu, ... Journal of Nuclear Medicine 57 (11), 1760-1763, 2016 | 29 | 2016 |
| Quantification in simultaneous 99mTc/123I brain SPECT using generalized spectral factor analysis: a Monte Carlo study S Hapdey, M Soret, I Buvat Physics in Medicine & Biology 51 (23), 6157, 2006 | 28 | 2006 |
| Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma? P Vera, MJ Ouvrier, S Hapdey, M Thillays, AS Pesquet, B Diologent, ... European journal of nuclear medicine and molecular imaging 34, 1943-1952, 2007 | 27 | 2007 |
| Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer P Vera, B Dubray, O Palie, I Buvat, S Hapdey, R Modzelewski, ... EJNMMI research 4, 1-9, 2014 | 23 | 2014 |
| Spectral factor analysis for multi-isotope imaging in nuclear medicine I Buvat, S Hapdey, H Benali, A Todd-Pokropek, R Di Paola Biennial International Conference on Information Processing in Medical …, 1999 | 18 | 1999 |
| Realistic and efficient modeling of radiotracer heterogeneity in Monte Carlo simulations of PET images with tumors S Stute, S Vauclin, H Necib, N Grotus, P Tylski, NS Rehfeld, S Hapdey, ... IEEE Transactions on Nuclear Science 59 (1), 113-122, 2012 | 17 | 2012 |
| Segmentation des images TEP au 18F-FDG. Principe et revue de la littérature S Vauclin, I Gardin, K Doyeux, S Hapdey, A Edet-Sanson, P Vera Médecine Nucléaire 34 (6), 358-369, 2010 | 17 | 2010 |
